MicroRNA-206: A promising theranostic marker

Theranostics

Volumn 4, Issue 2, 2014, Pages 119-133

  Novák, Jan ^a,b   Kružliak, Peter ^a   Bienertová Vaškü, Julie ^b,c   Slabý, Ondřej ^c   Novák, Miroslav ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c CENTRAL EUROPEAN INSTITUTE OF TECHNOLOGY   (Czech Republic)

Author keywords

MicroRNA 206; Theranostic marker

Indexed keywords

MICRORNA-206; THERANOSTIC MARKER;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BIOLOGICAL PRODUCTS; HEART FAILURE; HUMANS; MICRORNAS; MUSCLE, SKELETAL; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84893630323     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.7552     Document Type: Review

References (134)

1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-54.
2. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic acids research. 2011; 39: D152-7. doi:10.1093/nar/gkq1027.
3. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. Journal of physiology and biochemistry. 2011; 67: 129-39. doi:10.1007/s13105-010-0050-6.
4. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433: 769-73. doi:10.1038/nature03315.
5. McCarthy JJ. MicroRNA-206: the skeletal muscle-specific myomiR. Biochimica et biophysica acta. 2008; 1779: 682-91. doi:10.1016/j.bbagrm.2008.03.001.
6. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Developmental cell. 2009; 17: 662-73. doi:10.1016/j.devcel.2009.10.013.
7. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Current biology: CB. 2002; 12: 735-9.
8. Townley-Tilson WH, Callis TE, Wang D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. The international journal of biochemistry & cell biology. 2010; 42: 1252-5. doi:10.1016/j.biocel.2009.03.002.
9. Novak J, Vinklarek J, Bienertova-Vasku J, Slaby O. MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis. Pediatric blood & cancer. 2013. doi:10.1002/pbc.24664.
10. Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PloS one. 2011; 6: e19845. doi:10.1371/journal.pone.0019845.
11. Zhou J, Tian Y, Li J, Lu B, Sun M, Zou Y, et al. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2. Biochemical and biophysical research communications. 2013; 433: 207-12. doi:10.1016/j.bbrc.2013.02.084.
12. Zhang L, Liu X, Jin H, Guo X, Xia L, Chen Z, et al. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett. 2013; 332: 94-101. doi:10.1016/j.canlet.2013.01.023.
13. Wang X, Ling C, Bai Y, Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anatomical record (Hoboken, NJ: 2007). 2011; 294: 88-92. doi:10.1002/ar.21287.
14. Yue J, Guan J, Wang X, Zhang L, Yang Z, Ao Q, et al. MicroRNA-206 is involved in hypoxia-induced pulmonary hypertension through targeting of the HIF-1alpha/Fhl-1 pathway. Lab Invest. 2013; 93: 748-59. doi:10.1038/labinvest.2013.63.
15. Liu FJ, Lim KY, Kaur P, Sepramaniam S, Armugam A, Wong PT, et al. microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model. PloS one. 2013; 8: e66393. doi:10.1371/journal.pone.0066393.
16. Donaldson A, Natanek SA, Lewis A, Man WD, Hopkinson NS, Polkey MI, et al. Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax. 2013; doi:10.1136/thoraxjnl-2012-203129.
17. Haas JD, Nistala K, Petermann F, Saran N, Chennupati V, Schmitz S, et al. Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in alphabeta and gammadelta T cells. PloS one. 2011; 6: e20171. doi:10.1371/journal.pone.0020171.
18. Bentzinger CF, Wang YX, Rudnicki MA. Building muscle: molecular regulation of myogenesis. Cold Spring Harbor perspectives in biology. 2012; 4. doi:10.1101/cshperspect.a008342.
19. Sweetman D, Goljanek K, Rathjen T, Oustanina S, Braun T, Dalmay T, et al. Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Developmental biology. 2008; 321: 491-9. doi:10.1016/j.ydbio.2008.06.019.
20. Hirai H, Verma M, Watanabe S, Tastad C, Asakura Y, Asakura A. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. The Journal of cell biology. 2010; 191: 347-65. doi:10.1083/jcb.201006025.
21. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. The Journal of cell biology. 2006; 175: 77-85. doi:10.1083/jcb.200603039.
22. Macquarrie KL, Yao Z, Young JM, Cao Y, Tapscott SJ. miR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells. Skelet Muscle. 2012; 2: 7. doi:10.1186/2044-5040-2-7.
23. Gagan J, Dey BK, Layer R, Yan Z, Dutta A. Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts. The Journal of biological chemistry. 2012; 287: 40360-70. doi:10.1074/jbc. M112.378414.
24. Rachagani S, Cheng Y, Reecy JM. Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle. BMC research notes. 2010; 3: 297. doi:10.1186/1756-0500-3-297.
25. Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S, et al. Polymorphic microRNA-target interactions: a novel source of phenotypic variation. Cold Spring Harbor symposia on quantitative biology. 2006; 71: 343-50. doi:10.1101/sqb.2006.71.056.
26. Song G, Wang L. Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PloS one. 2009; 4: e6880. doi:10.1371/journal.pone.0006880.
27. Lu L, Zhou L, Chen EZ, Sun K, Jiang P, Wang L, et al. A Novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PloS one. 2012; 7: e27596. doi:10.1371/journal.pone.0027596.
28. Radzikinas K, Aven L, Jiang Z, Tran T, Paez-Cortez J, Boppidi K, et al. A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle. J Neurosci. 2011; 31: 15407-15. doi:10.1523/jneurosci.2745-11.2011.
29. Sweetman D, Rathjen T, Jefferson M, Wheeler G, Smith TG, Wheeler GN, et al. FGF-4 signaling is involved in mir-206 expression in developing somites of chicken embryos. Developmental dynamics: an official publication of the American Association of Anatomists. 2006; 235: 2185-91. doi:10.1002/dvdy.20881.
30. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, et al. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. The Journal of biological chemistry. 2011; 286: 13805-14. doi:10.1074/jbc. M110.192625.
31. Dong H, Paquette M, Williams A, Zoeller RT, Wade M, Yauk C. Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs. PloS one. 2010; 5: e12136. doi:10.1371/journal.pone.0012136.
32. Visser WE, Heemstra KA, Swagemakers SM, Ozgur Z, Corssmit EP, Burggraaf J, et al. Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. The Journal of clinical endocrinology and metabolism. 2009; 94: 3487-96. doi:10.1210/jc.2009-0782.
33. Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Molecular endocrinology (Baltimore, Md). 2007; 21: 1132-47. doi:10.1210/me.2007-0022.
34. Sato MM, Nashimoto M, Katagiri T, Yawaka Y, Tamura M. Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochemical and biophysical research communications. 2009; 383: 125-9. doi:10.1016/j.bbrc.2009.03.142.
35. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. The Journal of cell biology. 1994; 127: 1755-66.
36. Katagiri T, Akiyama S, Namiki M, Komaki M, Yamaguchi A, Rosen V, et al. Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Experimental cell research. 1997; 230: 342-51. doi:10.1006/excr.1996.3432.
37. Drummond MJ, Glynn EL, Fry CS, Dhanani S, Volpi E, Rasmussen BB. Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. The Journal of nutrition. 2009; 139: 2279-84. doi:10.3945/jn.109.112797.
38. Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, Yamamoto K, et al. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PloS one. 2011; 6: e18388. doi:10.1371/journal.pone.0018388.
39. Aoi W, Ichikawa H, Mune K, Tanimura Y, Mizushima K, Naito Y, et al. Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men. Front Physiol. 2013; 4: 80. doi:10.3389/fphys.2013.00080.
40. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, Bertini E, et al. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med. 2011; 3: 258-65. doi:10.1002/emmm.201100133.
41. Nicholson GA, Morgan GJ, Meerkin M, Strauss ER, McLeod JG. The effect of aerobic exercise on serum creatine kinase activities. Muscle & nerve. 1986; 9: 820-4. doi:10.1002/mus.880090905.
42. Nielsen S, Scheele C, Yfanti C, Akerstrom T, Nielsen AR, Pedersen BK, et al. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. The Journal of physiology. 2010; 588: 4029-37. doi:10.1113/jphysiol.2010.189860.
43. Allen DL, Bandstra ER, Harrison BC, Thorng S, Stodieck LS, Kostenuik PJ, et al. Effects of spaceflight on murine skeletal muscle gene expression. Journal of applied physiology (Bethesda, Md: 1985). 2009; 106: 582-95. doi:10.1152/japplphysiol.90780.2008.
44. Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol. 2011; 11: 34. doi:10.1186/1471-213x-11-34.
45. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. The Journal of cell biology. 2006; 174: 677-87. doi:10.1083/jcb.200603008.
46. Shkumatava A, Stark A, Sive H, Bartel DP. Coherent but overlapping expression of microRNAs and their targets during vertebrate development. Genes & development. 2009; 23: 466-81. doi:10.1101/gad.1745709.
47. Hou X, Tang Z, Liu H, Wang N, Ju H, Li K. Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs. PloS one. 2012; 7: e52123. doi:10.1371/journal.pone.0052123.
48. Xie SS, Huang TH, Shen Y, Li XY, Zhang XX, Zhu MJ, et al. Identification and characterization of microRNAs from porcine skeletal muscle. Animal genetics. 2010; 41: 179-90. doi:10.1111/j.1365-2052.2009.01991.x.
49. Yan X, Ding L, Li Y, Zhang X, Liang Y, Sun X, et al. Identification and profiling of microRNAs from skeletal muscle of the common carp. PloS one. 2012; 7: e30925. doi:10.1371/journal.pone.0030925.
50. Takada S, Berezikov E, Yamashita Y, Lagos-Quintana M, Kloosterman WP, Enomoto M, et al. Mouse microRNA profiles determined with a new and sensitive cloning method. Nucleic acids research. 2006; 34: e115. doi:10.1093/nar/gkl653.
51. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, et al. Dicer is essential for mouse development. Nature genetics. 2003; 35: 215-7. doi:10.1038/ng1253.
52. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, et al. Essential role for Dicer during skeletal muscle development. Developmental biology. 2007; 311: 359-68. doi:10.1016/j.ydbio.2007.08.032.
53. Nakajima N, Takahashi T, Kitamura R, Isodono K, Asada S, Ueyama T, et al. MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochemical and biophysical research communications. 2006; 350: 1006-12. doi:10.1016/j.bbrc.2006.09.153.
54. Goljanek-Whysall K, Sweetman D, Abu-Elmagd M, Chapnik E, Dalmay T, Hornstein E, et al. MicroRNA regulation of the paired-box transcription factor Pax3 confers robustness to developmental timing of myogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 11936-41. doi:10.1073/pnas.1105362108.
55. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic acids research. 2006; 34: 5863-71. doi:10.1093/nar/gkl743.
56. Cerletti M, Shadrach JL, Jurga S, Sherwood R, Wagers AJ. Regulation and function of skeletal muscle stem cells. Cold Spring Harbor symposia on quantitative biology. 2008; 73: 317-22. doi:10.1101/sqb.2008.73.054.
57. Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. The Journal of cell biology. 2010; 190: 867-79. doi:10.1083/jcb.200911036.
58. Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. Journal of cellular and molecular medicine. 2010; 14: 2495-505. doi:10.1111/j.1582-4934.2009.00898.x.
59. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, NY). 2009; 326: 1549-54. doi:10.1126/science.1181046.
60. Miura P, Amirouche A, Clow C, Belanger G, Jasmin BJ. Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206. J Neurochem. 2012; 120: 230-8. doi:10.1111/j.1471-4159.2011.07583.x.
61. Jeng S F, Rau CS, Liliang P C, Wu CJ, Lu TH, Chen YC, et al. Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. Journal of neurotrauma. 2009; 26: 2345-53. doi:10.1089/neu.2009.0960.
62. Rau CS, Jeng JC, Jeng SF, Lu TH, Chen YC, Liliang PC, et al. Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats. BMC musculoskeletal disorders. 2010; 11: 181. doi:10.1186/1471-2474-11-181.
63. Bruneteau G, Simonet T, Bauche S, Mandjee N, Malfatti E, Girard E, et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain: a journal of neurology. 2013; 136: 2359-68. doi:10.1093/brain/awt164.
64. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. The New England journal of medicine. 1988; 318: 1363-8. doi:10.1056/nejm198805263182104.
65. Turner C, Hilton-Jones D. The myotonic dystrophies: diagnosis and management. Journal of neurology, neurosurgery, and psychiatry. 2010; 81: 358-67. doi:10.1136/jnnp.2008.158261.
66. McCarthy JJ, Esser KA, Andrade FH. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. American journal of physiology Cell physiology. 2007; 293: C451-7. doi:10.1152/ajpcell.00077.2007.
67. Roberts TC, Blomberg KE, McClorey G, El Andaloussi S, Godfrey C, Betts C, et al. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids. 2012; 1: e39. doi:10.1038/mtna.2012.26.
68. Yuasa K, Hagiwara Y, Ando M, Nakamura A, Takeda S, Hijikata T. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell structure and function. 2008; 33: 163-9.
69. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2009; 23: 3335-46. doi:10.1096/fj.08-128579.
70. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell metabolism. 2010; 12: 341-51. doi:10.1016/j.cmet.2010.07.008.
71. Perbellini R, Greco S, Sarra-Ferraris G, Cardani R, Capogrossi MC, Meola G, et al. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscular disorders: NMD. 2011; 21: 81-8. doi:10.1016/j.nmd.2010.11.012.
72. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, Angelini C, et al. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. Journal of translational medicine. 2010; 8: 48. doi:10.1186/1479-5876-8-48.
73. Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. The Journal of clinical investigation. 2012; 122: 2054-65. doi:10.1172/jci62656.
74. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clinic proceedings Mayo Clinic. 2012; 87: 475-87. doi:10.1016/j.mayocp.2012.01.015.
75. Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H, et al. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. The American journal of pathology. 2009; 174: 550-64. doi:10.2353/ajpath.2009.080631.
76. Yan D, Dong Xda E, Chen X, Wang L, Lu C, Wang J, et al. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. The Journal of biological chemistry. 2009; 284: 29596-604. doi:10.1074/jbc. M109.020511.
77. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, et al. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. The Journal of clinical investigation. 2009; 119: 2366-78. doi:10.1172/jci38075.
78. Taulli R, Foglizzo V, Morena D, Coda DM, Ala U, Bersani F, et al. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. Oncogene. 2013. doi:10.1038/onc.2013.188.
79. Miyachi M, Tsuchiya K, Yoshida H, Yagyu S, Kikuchi K, Misawa A, et al. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochemical and biophysical research communications. 2010; 400: 89-93. doi:10.1016/j.bbrc.2010.08.015.
80. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, et al. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. British journal of cancer. 2010; 102: 1769-77. doi:10.1038/sj.bjc.6605684.
81. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA: a cancer journal for clinicians. 2008; 58: 71-96. doi:10.3322/ca.2007.0010.
82. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer research. 2005; 65: 7065-70. doi:10.1158/0008-5472.can-05-1783.
83. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer research. 2008; 68: 5004-8. doi:10.1158/0008-5472.can-08-0180.
84. Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, et al. Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer. Breast Cancer Res Treat. 2011; 130: 331-9. doi:10.1007/s10549-011-1672-2.
85. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, et al. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. Journal of the National Cancer Institute. 2010; 102: 706-21. doi:10.1093/jnci/djq102.
86. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene. 2009; 28: 3926-36. doi:10.1038/onc.2009.241.
87. Adams BD, Cowee DM, White BA. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. Molecular endocrinology (Baltimore, Md). 2009; 23: 1215-30. doi:10.1210/me.2009-0062.
88. Munagala R, Aqil F, Vadhanam MV, Gupta RC. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. Cancer Lett. 2013. doi:10.1016/j.canlet.2013.06.012.
89. Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology. 2009; 150: 14-23. doi:10.1210/en.2008-0984.
90. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008; 451: 147-52. doi:10.1038/nature06487.
91. Li Y, Hong F, Yu Z. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival. J Int Med Res. 2013; 41: 596-602. doi:10.1177/0300060513485856.
92. Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, Millikan RC. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control. 2013; 24: 1099-109. doi:10.1007/s10552-013-0187-z.
93. Guo R, Wu Q, Liu F, Wang Y. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Oncology reports. 2011; 25: 141-6.
94. Zhou L, Chen J, Li Z, Li X, Hu X, Huang Y, et al. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PloS one. 2010; 5: e15224. doi:10.1371/journal.pone.0015224.
95. Torres-Martin M, Lassaletta L, de Campos JM, Isla A, Gavilan J, Pinto GR, et al. Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32. PloS one. 2013; 8: e65868. doi:10.1371/journal.pone.0065868.
96. Vickers MM, Bar J, Gorn-Hondermann I, Yarom N, Daneshmand M, Hanson JE, et al. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis. 2012; 29: 123-32. doi:10.1007/s10585-011-9435-3.
97. Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, et al. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur J Gastroenterol Hepatol. 2013; 25: 953-7. doi:10.1097/MEG.0b013e32835ed691.
98. Wang C, Su Z, Sanai N, Xue X, Lu L, Chen Y, et al. microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment. Oncology reports. 2012; 27: 1312-20. doi:10.3892/or.2012.1690.
99. Zhang T, Liu M, Wang C, Lin C, Sun Y, Jin D. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res. 2011; 31: 3859-63.
100. Stahlhut C, Suarez Y, Lu J, Mishima Y, Giraldez AJ. miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. Development. 2012; 139: 4356-64. doi:10.1242/dev.083774.
101. Chen X, Yan Q, Li S, Zhou L, Yang H, Yang Y, et al. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett. 2012; 314: 41-53. doi:10.1016/j.canlet.2011.09.014.
102. Lin CC, Liu LZ, Addison JB, Wonderlin WF, Ivanov AV, Ruppert JM. A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Molecular and cellular biology. 2011; 31: 2513-27. doi:10.1128/mcb.01189-10.
103. Parasramka MA, Dashwood WM, Wang R, Saeed HH, Williams DE, Ho E, et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Kruppel-like factor 4 (KLF4) axis. Clin Epigenetics. 2012; 4: 16. doi:10.1186/1868-7083-4-16.
104. Wu J, Yang T, Li X, Yang Q, Liu R, Huang J, et al. Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Toxicol Appl Pharmacol. 2013; 267: 238-46. doi:10.1016/j.taap.2013.01.002.
105. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PloS one. 2012; 7: e48086. doi:10.1371/journal.pone.0048086.
106. Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC medical genomics. 2012; 5: 3. doi:10.1186/1755-8794-5-3.
107. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sanudo A, Camara-Lopes LH, et al. MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol. 2011. doi:10.1016/j.urolonc.2011.07.002.
108. Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget. 2012; 3: 44-57.
109. Wang R, Hu Y, Song G, Hao CJ, Cui Y, Xia HF, et al. MiR-206 regulates neural cells proliferation and apoptosis via Otx2. Cell Physiol Biochem. 2012; 29: 381-90. doi:10.1159/000338493.
110. Roccaro AM, Sacco A, Jia X, Azab AK, Maiso P, Ngo HT, et al. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood. 2010; 116: 1506-14. doi:10.1182/blood-2010-01-265686.
111. Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL, et al. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. FEBS letters. 2010; 584: 3592-600. doi:10.1016/j.febslet.2010.07.027.
112. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochemical and biophysical research communications. 2009; 381: 597-601. doi:10.1016/j.bbrc.2009.02.097.
113. Westendorp B, Major JL, Nader M, Salih M, Leenen FH, Tuana BS. The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2012; 26: 2569-79. doi:10.1096/fj.11-203174.
114. Song G, Zhang Y, Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. The Journal of biological chemistry. 2009; 284: 31921-7. doi:10.1074/jbc. M109.046862.
115. Jalali S, Ramanathan GK, Parthasarathy PT, Aljubran S, Galam L, Yunus A, et al. Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation. PloS one. 2012; 7: e46808. doi:10.1371/journal.pone.0046808.
116. Farber HW, Loscalzo J. Pulmonary arterial hypertension. The New England journal of medicine. 2004; 351: 1655-65. doi:10.1056/NEJMra035488.
117. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J, et al. Downregulation of the serum response factor/miR-1 a xis i n t he quadriceps of patients with COPD. Thorax. 2012; 67: 26-34. doi:10.1136/thoraxjnl-2011-200309.
118. Guo XK, Zhang Q, Gao L, Li N, Chen XX, Feng WH. Increasing expression of microRNA 181 inhibits porcine reproductive and respiratory syndrome virus replication and has implications for controlling virus infection. J Virol. 2013; 87: 1159-71. doi:10.1128/jvi.02386-12.
119. Skovgaard K, Cirera S, Vasby D, Podolska A, Breum SO, Durrwald R, et al. Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2). Innate Immun. 2013 doi:10.1177/1753425912473668.
120. Ge Y, Zhao K, Qi Y, Min X, Shi Z, Qi X, et al. Serum microRNA expression profile as a biomarker for the diagnosis of pertussis. Mol Biol Rep. 2013; 40: 1325-32. doi:10.1007/s11033-012-2176-9.
121. Olsen L, Klausen M, Helboe L, Nielsen FC, Werge T. MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats. PloS one. 2009; 4: e7225. doi:10.1371/journal.pone.0007225.
122. Lehotzky A, Lau P, Tokesi N, Muja N, Hudson LD, Ovadi J. Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation. Glia. 2010; 58: 157-68. doi:10.1002/glia.20909.
123. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke, a journal of cerebral circulation. 2008; 39: 959-66. doi:10.1161/strokeaha.107.500736.
124. Lee ST, Chu K, Jung KH, Kim JH, Huh JY, Yoon H, et al. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol. 2012; 72: 269-77. doi:10.1002/ana.23588.
125. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, et al. Brain expressed microRNAs implicated in schizophrenia etiology. PloS one. 2007; 2: e873. doi:10.1371/journal.pone.0000873.
126. Carter CJ. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophrenia bulletin. 2009; 35: 1163-82. doi:10.1093/schbul/sbn054.
127. Koba S, Jinnin M, Inoue K, Nakayama W, Honda N, Makino K, et al. Expression analysis of multiple microRNAs in each patient with scleroderma. Exp Dermatol. 2013; 22: 489-91. doi:10.1111/exd.12173.
128. Greco SJ, Rameshwar P. MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104: 15484-9. doi:10.1073/pnas.0703037104.
129. Kusuda R, Cadetti F, Ravanelli MI, Sousa TA, Zanon S, De Lucca FL, et al. Differential expression of microRNAs in mouse pain models. Molecular pain. 2011; 7: 17. doi:10.1186/1744-8069-7-17.
130. Zhou W, Li Y, Wang X, Wu L, Wang Y. MiR-206-mediated dynamic mechanism of the mammalian circadian clock. BMC Syst Biol. 2011; 5: 141. doi:10.1186/1752-0509-5-141.
131. Walden TB, Timmons JA, Keller P, Nedergaard J, Cannon B. Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. Journal of cellular physiology. 2009; 218: 444-9. doi:10.1002/jcp.21621.
132. Zhong D, Huang G, Zhang Y, Zeng Y, Xu Z, Zhao Y, et al. MicroRNA-1 and microRNA-206 suppress LXRalpha-induced lipogenesis in hepatocytes. Cell Signal. 2013; 25: 1429-37. doi:10.1016/j.cellsig.2013.03.003.
133. Soriano A, Jubierre L, Almazan-Moga A, Molist C, Roma J, de Toledo JS, et al. microRNAs as pharmacological targets in cancer. Pharmacological research: the official journal of the Italian Pharmacological Society. 2013; 75: 3-14. doi:10.1016/j.phrs.2013.03.006.
134. Meloche J, Paulin R, Provencher S, Bonnet S. Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension. Curr Vasc Pharmacol. 2013.